Jonsson Comprehensive Cancer Center
Clinical trials sponsored by Jonsson Comprehensive Cancer Center, explained in plain language.
-
New hope: drug may shield brain from CAR T-Cell therapy side effects
Disease control TerminatedThis study tested whether the drug anakinra could prevent severe brain inflammation (called ICANS) that sometimes happens after CAR T-cell therapy for certain types of lymphoma. The trial involved 23 adults whose lymphoma had returned or not responded to prior treatments. Researc…
Phase: PHASE2 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Laser zaps prostate tumors in tiny study
Disease control TerminatedThis study tested a new way to treat prostate cancer using a laser guided by MRI images. Only 2 men took part before the study was stopped. The goal was to see if the treatment was safe and could precisely target cancer while avoiding healthy tissue.
Phase: NA • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC